The problem: regulatory documentation scattered everywhere
In the pharmaceutical industry, compliance depends on mastering the texts. But those texts are everywhere and nowhere at once: FDA, EMA, ICH, PIC/S, EudraLex, WHO, pharmacopoeias, sector association guides… Each body publishes, updates, revises. Meanwhile, field teams juggle dozens of tabs, PDFs downloaded on unknown dates, and cross-references that no longer point to the right versions.
The real risk is not ignorance. It is working in good faith on an outdated text, missing a recent guidance, or spending an hour cross-referencing three documents to answer a question that comes up every month.
This problem affects every function: regulatory affairs, quality assurance, validation, equipment qualification, data integrity. Wherever decisions rely on texts, document fragmentation wastes time — and sometimes much more.
How Ring came to be: three partners, one goal
Ring did not come from a generalist tech lab. It was born from a sector-driven initiative led by three partners who know the industry from the inside:
- Aktehom — an independent consulting firm dedicated to life science companies, with over 20 years of existence and a team of 65 specialists. It covers the full product lifecycle (small molecule, biotech, innovative therapies, medical devices, cosmetics) with technical, scientific, regulatory and human expertise built from the field. Aktehom initiated the Ring project and remains its regulatory quality guarantor.
- A3P (Association for Clean and Sterile Products) — a European reference network dedicated to health industries, with more than 9,000 members and 30 years of field expertise. Its GST A3P technical guides and La Vague journal are recognised sector references. A3P contributes documentary authority, an expert network, and experience gathered from annual congresses and training events.
- Mindexia — a specialist in sovereign knowledge management and generative AI, built for industries with high document density. Responsible for the Ring platform architecture: vectorisation, RAG pipelines, semantic ranking and verifiable citations. Mindexia also handles hosting in France (OVH), GDPR compliance and continuous improvement of indexing and relevance processes.
This positioning has a direct consequence: Ring is a tool designed for regulated professionals, not a general-purpose chatbot. User data is neither retained nor used to train the model. Inference is ephemeral. Communications are encrypted. It is infrastructure designed to operate in GxP environments.
An answer engine, not just a search tool
This is where Ring differs from a conventional search engine. You do not search for a document — you ask a question. Ring analyses the query, searches its entire documentary base, identifies the most relevant passages, and generates a structured response anchored in those sources, with exact citation of the originating document.
Technically, this relies on a RAG (Retrieval-Augmented Generation) architecture: the answer is never generated "from nothing". It is built from what exists in the texts. This eliminates the hallucinations characteristic of unconstrained generative AI, and ensures that every claim can be traced back to a verifiable source.
In practice: you ask a question in plain language, you get a clear answer with the references of the texts that support it. No need to know which document to look in, or which version is current.
The largest life science documentary base available today
What makes Ring credible is the breadth and quality of its base. More than 28 technical and regulatory life science sources, representing nearly 1,700 current documents, all structured and queryable. No equivalent tool aggregates this many sector referentials in a single place today.
The scope covers:
- Regulatory authorities: FDA, EMA, ANSM, Swissmedic, MHRA, TGA, PMDA, Health Canada, ANVISA, NMPA, MFDS…
- International harmonisation: ICH (Q1–Q14, E and S series), WHO, OECD
- GMP & inspection: PIC/S (54 member authorities), EudraLex volumes 1–10 with all Annexes
- Quality & pharmacopoeias: EDQM, Indian Pharmacopoeia (IPC)
- Sector associations: A3P, Leem, BioPhorum, IPEC, APIC, IPA, ASPEC
- Inspection corpus: over 3,000 FDA Warning Letters and Form 483s indexed
Every source is kept current. When a guidance is revised, the base integrates it — and your answers reflect the version in force.
Ring in cleaning validation: 3 concrete questions
To measure what Ring actually delivers, here are three questions asked directly to the tool on common cleaning validation topics.
Recovery rates: thresholds and validation methodology
"How do you validate recovery rates? What thresholds should be achieved?"
Ring structures its response around three acceptability levels, grounded in ICH Q2:
- ≥ 70%: satisfactory result, no correction required.
- 50–70%: acceptable under condition — the analytical result must be corrected by the recovery factor.
- < 50%: not acceptable. The method must be revised: swab type, solvent, operating procedure.
The response also notes that microbiological methods generally do not require recovery validation, and recalls robustness criteria (inter-operator variability, repeatability). What would have required reading ICH Q2 and the A3P guide is obtained here in seconds, with the references cited.
Worst-case strategy: how to build a product grouping
"How do you implement worst-case product groupings in cleaning validation?"
Ring delivers a structured five-step approach: grouping by process similarity, worst-case selection using weighted criteria (cleanability, solubility, toxicity/PDE, potency), documented justification of the selection, validation on the group's worst case, then reassessment at each change.
An often underestimated point is highlighted: the need to reassess the strategy when each new product is introduced. This is exactly the kind of reminder that is useful before an inspection, or for a colleague picking up a dossier.
Equipment drying: optimisation and regulatory framework
"How do you optimise the drying phases of cleaning processes for product-contact equipment?"
Ring immediately frames the topic: drying is not an accessory step, it is a full component of the cleaning process, directly governed by Annex 1 and the concept of Clean Hold Time (CHT). On the operational side, it lists available levers — filtered hot air blowing, vacuum drying for complex geometries, equipment design without retention zones — while recalling that critical parameters must be defined, validated and maintained.
In a single response, Ring provides the regulatory framework and the technical options. This removes the need to separately review Annex 1, equipment guides and inspection feedback to piece together the full picture.
What Ring changes — and what it does not replace
The immediate gain is search time. Finding the regulatory position on a specific topic, identifying the reference text, confirming you are working on the current version: all of this used to take an hour. Ring compresses it to a few seconds.
There is also a less visible benefit: active regulatory watch. Ring does not just integrate documentary updates — it alerts. Each user defines a list of topics of interest in their profile (audit, GMP & GDP, sterile, cleaning validation, data integrity…) and receives an email as soon as a new document related to those themes is added to the base. No more risk of missing a published guidance without knowing it.
Ring is also a competency-building tool for less experienced profiles: sourced responses give them a solid documentary anchor, without needing to consult a senior expert for every substantive question.
That said, Ring does not replace professional judgement. A response extracted from a corpus remains a starting point: contextual interpretation — adapting to your site, equipment, inspection history — remains the practitioner's responsibility. Ring answers on the texts; it does not do the analytical work for you.
Conclusion
Ring fills a real gap: fast, reliable and sourced access to regulatory and technical documentation for the health industry. For cleaning validation teams, it means the end of dispersed searches across ICH Q2, Annex 15, PIC/S and a dozen other sources — replaced by a single interface that answers, cites and stays current.
Try it directly at ring.a3p.org.
For the operational side — MACO calculations, acceptance criteria, cleaning strategy documentation — that is precisely what Hally handles.